MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 72 filers reported holding MEI PHARMA INC in Q3 2019. The put-call ratio across all filers is 13.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,939 | -12.3% | 12,839 | -6.7% | 0.00% | – |
| Q4 2022 | $3,353 | -32.9% | 13,763 | -0.0% | 0.00% | – |
| Q3 2022 | $5,000 | -54.5% | 13,768 | -21.6% | 0.00% | – |
| Q2 2022 | $11,000 | +22.2% | 17,562 | -0.7% | 0.00% | – |
| Q1 2022 | $9,000 | -79.5% | 17,680 | +7.3% | 0.00% | – |
| Q4 2021 | $44,000 | +15.8% | 16,481 | +20.5% | 0.00% | – |
| Q3 2021 | $38,000 | -7.3% | 13,680 | -4.8% | 0.00% | – |
| Q2 2021 | $41,000 | -25.5% | 14,370 | -9.7% | 0.00% | – |
| Q1 2021 | $55,000 | +27.9% | 15,905 | -3.0% | 0.00% | – |
| Q4 2020 | $43,000 | -4.4% | 16,400 | +13.2% | 0.00% | – |
| Q3 2020 | $45,000 | -26.2% | 14,492 | -2.0% | 0.00% | – |
| Q2 2020 | $61,000 | +45.2% | 14,792 | -43.3% | 0.00% | – |
| Q1 2020 | $42,000 | +133.3% | 26,074 | +141.8% | 0.00% | – |
| Q3 2019 | $18,000 | – | 10,783 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |